BJ4-13403-47826
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 154 / PA
- Registered
- 2021-09-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-01
Dose 1 — Pfizer-BioNTech
-
2021-09-08
Registered in v-safe
- 2021-09-08
- 2021-09-15
-
2021-09-22
Dose 2 — Pfizer-BioNTech
-
2021-09-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness, NauseaAdult check-in
-
2021-09-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-09-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, NauseaAdult check-in
- 2021-09-26
-
2021-09-27
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea, Sneezing — Feeling: Fair · Headache, Joint pains, Fatigue or tiredness, NauseaFree text: Runny Nose, SneezingMedDRA releases: 2024-11 · check-in free text available
- 2021-09-29
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-12-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-01 | Pfizer-BioNTech | No |
| 2 | 2021-09-22 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Runny Nose, Sneezing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release